Tranexamic Acid Infusion During Elective Spine Surgery

Enrolling by invitation · Phase 4

Conditions studied: Spine Surgery

In brief

Tranexamic acid (TXA) is an agent that has been shown to be safe and effective to reduce blood loss in surgical procedures. The purpose of the study is to assess the effect of transexamic on elective decompressive lumbar spine surgery with and without fusion.

Key facts

Study ID

NCT04312880

Run by

Albany Medical College

People needed

65

Starts

2018-12-01

Expected to finish

2021-01-01

Last updated by the study team

2020-08-12

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients undergoing decompressive lumbar laminectomy with or without fusion
• Primary surgical procedure
• Competent adult able to give informed consent
• Age >18

You may not qualify if…

• h/o DVT or PE
• h/o seizure
• h/o coagulopathy
• Diagnosis of malignancy or infection as indication for surgical decompression
• Abnormal pre-operative PT/INR, aPTT, bleeding time
• Platelet count < 100
• Patients requiring therapeutic heparin or lovenox bridges prior to and/or after surgery
• Allergy to TXA
• Pregnant women and prisoners
• Renal insufficiency

Where it is running

• Albany Medical Center — Albany, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.